TAB1 monoclonal antibodies are widely used for:
TAK1 Activation: TAB1 binding induces TAK1 autophosphorylation, activating downstream JNK and NF-κB pathways critical in inflammation and cancer .
p38α MAPK Interaction: TAB1 directly activates p38α, contributing to stress responses and apoptosis .
Infectious Disease Role: TAB1-linked pathways influence cytokine storms in severe viral infections (e.g., COVID-19) .
Cancer: TAB1 overexpression correlates with tumor progression in breast and pancreatic cancers .
Autoimmune Diseases: Inhibiting TAB1-TAK1 interaction reduces inflammation in rheumatoid arthritis models .
Species Cross-Reactivity: Some clones (e.g., C25E9) show limited reactivity to non-human primates .
Batch Variability: Protein A-purified antibodies may require revalidation for quantitative assays .
Off-Target Effects: TAB1 antibodies may cross-react with homologous proteins in low-stringency conditions .